BE900650A - Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine. - Google Patents
Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine.Info
- Publication number
- BE900650A BE900650A BE0/213703A BE213703A BE900650A BE 900650 A BE900650 A BE 900650A BE 0/213703 A BE0/213703 A BE 0/213703A BE 213703 A BE213703 A BE 213703A BE 900650 A BE900650 A BE 900650A
- Authority
- BE
- Belgium
- Prior art keywords
- composition
- extract
- detoxified endotoxin
- refined detoxified
- microorganism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/535,037 US4663306A (en) | 1983-09-23 | 1983-09-23 | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
Publications (1)
Publication Number | Publication Date |
---|---|
BE900650A true BE900650A (fr) | 1985-03-21 |
Family
ID=24132594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/213703A BE900650A (fr) | 1983-09-23 | 1984-09-21 | Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4663306A (de) |
JP (1) | JPS60120817A (de) |
KR (1) | KR870000843B1 (de) |
AT (1) | AT385659B (de) |
AU (1) | AU566234B2 (de) |
BE (1) | BE900650A (de) |
CA (1) | CA1244765A (de) |
CH (1) | CH664897A5 (de) |
DE (1) | DE3434766C2 (de) |
DK (1) | DK446684A (de) |
ES (1) | ES8608872A1 (de) |
FI (1) | FI843716L (de) |
FR (1) | FR2552326B1 (de) |
GB (1) | GB2149301B (de) |
HU (1) | HU192585B (de) |
IL (1) | IL73034A (de) |
IN (1) | IN157240B (de) |
IT (1) | IT1179444B (de) |
NL (1) | NL8402902A (de) |
NO (1) | NO843776L (de) |
NZ (1) | NZ209635A (de) |
SE (1) | SE8404707L (de) |
ZA (1) | ZA847405B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4844894A (en) * | 1984-07-12 | 1989-07-04 | Ribi Immunochem Research Inc. | Method of inhibiting the onset of septicemia and endotoxemia |
US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
US4806352A (en) * | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
US4929604A (en) * | 1986-05-28 | 1990-05-29 | Board Of Regents, The University Of Texas System | Lipopolysaccharides of reduced toxicity and the production thereof |
DE69429521T2 (de) * | 1993-08-27 | 2002-07-18 | Vetrepharm, Inc. | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung |
US6090385A (en) * | 1993-12-10 | 2000-07-18 | Maes; Hubert | Method of treating cancer |
BE1007823A3 (fr) * | 1993-12-10 | 1995-10-31 | Anda Biolog Sa | Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer. |
US5976580A (en) | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
DE19710255A1 (de) * | 1997-03-13 | 1998-09-17 | Henkel Ecolab Gmbh & Co Ohg | Verwendung einer Lösung zur Desaktivierung von Endotoxinen |
KR100533576B1 (ko) | 1997-08-05 | 2005-12-05 | 바이오니취 라이프 사이언시즈 인코포레이티드 | 세포증식 및 세포사멸 조절용 조성물 및 방법 |
US6019985A (en) * | 1998-02-27 | 2000-02-01 | Munova Corporation | Immunostimulation methods for providing disease protection in poultry |
KR100628007B1 (ko) * | 1998-07-16 | 2006-09-26 | 이치로 아즈마 | 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제 |
CN100445380C (zh) * | 1999-12-13 | 2008-12-24 | 拜昂尼科生命科学有限公司 | 治疗用合成寡核苷酸 |
AU784356B2 (en) * | 1999-12-28 | 2006-03-16 | Bioniche Urology Ip Inc. | Hyaluronic acid in the treatment of cancer |
MXPA03000278A (es) * | 2000-07-11 | 2004-04-05 | Bayer Ag | Uso de cepas de parapoxvirus ovis frente a fibrosis de organos. |
WO2003074079A1 (fr) * | 2002-03-05 | 2003-09-12 | Cell-Medicine, Inc. | Adjuvant immunologique a base de tissus solidifies |
AU2003254792A1 (en) * | 2002-08-02 | 2004-02-23 | Sumitomo Pharmaceuticals Company, Limited | Bacterial cell wall skeleton component preparaion |
FR2848223B1 (fr) * | 2002-12-09 | 2005-02-25 | Centre Nat Rech Scient | Nouveau procede d'isolement des endotoxines. |
WO2005023277A1 (fr) * | 2003-09-05 | 2005-03-17 | Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. | Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale |
CA2564180A1 (en) * | 2004-04-22 | 2005-11-03 | Dainippon Sumitomo Pharma Co., Ltd. | Pharmaceutical preparation containing bacterial cell wall skeleton component |
CA2909221A1 (en) | 2013-04-18 | 2014-10-23 | Immune Design Corp. | Gla monotherapy for use in cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
CA2950945A1 (en) | 2014-06-17 | 2015-12-23 | Xycrobe Therapeutics, Inc. | Genetically modified bacteria and methods for genetic modification of bacteria |
WO2017147507A1 (en) | 2016-02-24 | 2017-08-31 | Xycrobe Therapeutics, Inc. | Skin probiotic formulation |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7308450A (de) * | 1972-06-20 | 1973-12-27 | ||
FR2269962B1 (de) * | 1974-05-06 | 1978-02-03 | Anvar | |
JPS58874B2 (ja) * | 1979-08-30 | 1983-01-08 | 株式会社 目黒研究所 | 糖蛋白wenac及びその製造法 |
US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
CA1209504A (en) * | 1982-06-30 | 1986-08-12 | John L. Cantrell | Pyridine soluble extract of a microorganism |
CA1206416A (en) * | 1982-06-30 | 1986-06-24 | John L. Cantrell | Pyridine soluble extract of a microorganism |
CA1206415A (en) * | 1982-06-30 | 1986-06-24 | John L. Cantrell | Pyridine soluble extract of a microorganism |
-
1983
- 1983-09-23 US US06/535,037 patent/US4663306A/en not_active Expired - Lifetime
-
1984
- 1984-09-19 DK DK446684A patent/DK446684A/da not_active Application Discontinuation
- 1984-09-20 SE SE8404707A patent/SE8404707L/xx not_active Application Discontinuation
- 1984-09-20 ZA ZA847405A patent/ZA847405B/xx unknown
- 1984-09-20 NO NO843776A patent/NO843776L/no unknown
- 1984-09-21 BE BE0/213703A patent/BE900650A/fr not_active IP Right Cessation
- 1984-09-21 CA CA000463800A patent/CA1244765A/en not_active Expired
- 1984-09-21 CH CH4544/84A patent/CH664897A5/de not_active IP Right Cessation
- 1984-09-21 FR FR8414533A patent/FR2552326B1/fr not_active Expired
- 1984-09-21 FI FI843716A patent/FI843716L/fi not_active Application Discontinuation
- 1984-09-21 NL NL8402902A patent/NL8402902A/nl not_active Application Discontinuation
- 1984-09-21 AU AU33400/84A patent/AU566234B2/en not_active Ceased
- 1984-09-21 GB GB08423993A patent/GB2149301B/en not_active Expired
- 1984-09-21 HU HU843585A patent/HU192585B/hu unknown
- 1984-09-21 NZ NZ209635A patent/NZ209635A/xx unknown
- 1984-09-21 ES ES536167A patent/ES8608872A1/es not_active Expired
- 1984-09-21 DE DE3434766A patent/DE3434766C2/de not_active Expired
- 1984-09-22 KR KR1019840005821A patent/KR870000843B1/ko active
- 1984-09-23 IL IL73034A patent/IL73034A/xx unknown
- 1984-09-24 AT AT0302384A patent/AT385659B/de not_active IP Right Cessation
- 1984-09-24 IT IT48894/84A patent/IT1179444B/it active
- 1984-09-25 IN IN677/CAL/84A patent/IN157240B/en unknown
- 1984-09-25 JP JP59198764A patent/JPS60120817A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE900650A (fr) | Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine. | |
FR2527443B1 (fr) | Composition contenant de l'endotoxine raffinee et medicament la contenant | |
ES8600215A1 (es) | Un procedimiento para preparar un oligopeptidos antigenico | |
AU6760987A (en) | Method of treating alzheimer's disease | |
LU91498I2 (fr) | Etanercept et ses dérivés pharmaceutiquement acceptables. | |
NO852872L (no) | Fremgangsmaate for fremstilling av nye tetrapyrroler. | |
ES8207119A1 (es) | Procedimiento para preparar complejos de platino (iv)-diami-na. | |
DE3583008D1 (de) | Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren. | |
OA07103A (fr) | Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant. | |
ES2010561A6 (es) | Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina. | |
ATE232394T1 (de) | Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs | |
ES2004245A6 (es) | Un procedimiento para la produccion de un anticuerpo monoclonal | |
GB2217330B (en) | Lipolytic material associated with cachexia inducing tumours, preparations,production and uses thereof. | |
HUT61202A (en) | Process for producing pharmaceutical compositions neutralizing procoagulant activity caused by tumour cells | |
DZ1390A1 (fr) | Procédé de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïque et de médicaments les contenant. | |
DE69720783D1 (de) | Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie | |
ES2068587T3 (es) | Medicamentos tumorales sustituidos con polieter. | |
ES8506806A1 (es) | Procedimiento para la preparacion de una proteina hipocolesterolemicamente activa | |
EP0096007A3 (en) | Pharmaceutical preparation containing (+)-cyanidan-3-ol derivatives, the use thereof, novel substituted (+)-cyanidan-3-ol derivatives, and processes for producing them | |
DE69026371D1 (de) | Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren | |
FR2550944B1 (fr) | Association pharmaceutique a base d'anticorps anticellules tumorales et de conjugues cytotoxiques, appropriee notamment pour le traitement des cancers | |
ZA884262B (en) | Pharmaceutical composition for the treatment of tumors | |
EP0254593A3 (de) | Herstellung und Verwendungen von gamma-Interferon | |
FR2631829B1 (fr) | Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant | |
IE871358L (en) | Interferon for carcinoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: RIBI IMMUNOCHEM RESEARCH INC. Effective date: 19900930 |